Cargando…
Homogeneous antibody fragment conjugation by disulfide bridging introduces ‘spinostics'
A major obstacle to the efficient production of antibody conjugates for therapy and diagnosis is the non-ideal performance of commonly used chemical methods for the attachment of effector-molecules to the antibody of interest. Here we demonstrate that this limitation can be simply addressed using 3,...
Autores principales: | Schumacher, Felix F., Sanchania, Vishal A., Tolner, Berend, Wright, Zoë V. F., Ryan, Chris P., Smith, Mark E. B., Ward, John M., Caddick, Stephen, Kay, Christopher W. M., Aeppli, Gabriel, Chester, Kerry A., Baker, James R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605607/ https://www.ncbi.nlm.nih.gov/pubmed/23519366 http://dx.doi.org/10.1038/srep01525 |
Ejemplares similares
-
Homogeneous
Bispecifics by Disulfide Bridging
por: Hull, Elizabeth A., et al.
Publicado: (2014) -
Next generation maleimides enable the controlled assembly of antibody–drug conjugates via native disulfide bond bridging
por: Schumacher, Felix F., et al.
Publicado: (2014) -
Acid-cleavable thiomaleamic acid linker for homogeneous antibody–drug conjugation
por: Castañeda, Lourdes, et al.
Publicado: (2013) -
Protein Modification, Bioconjugation, and Disulfide Bridging Using Bromomaleimides
por: Smith, Mark E. B., et al.
Publicado: (2010) -
In Situ Maleimide Bridging of Disulfides and a New Approach to Protein PEGylation
por: Schumacher, Felix F., et al.
Publicado: (2011)